Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.
AFLAC Incorporated (AFL) reported trailing twelve months (TTM) revenue of $17.36B as of December 2025, which represents a 9.2% decrease year-over-year. The company's operating margin has contracted to 32.7% from 38.8% a year ago. In terms of profitability, AFL generated $3.65B in net income. Valuation-wise, the stock trades at a P/E ratio of 16.2x and a Price-to-Sales (P/S) ratio of 3.4x. The company generated $315.00M in free cash flow over the last twelve months, indicating its ability to reinvest in growth or return capital to shareholders. Data based on the most recent quarterly reports.
Quarterly standardized metrics.
Stock price and market valuation
Top-line sales performance
EBITDA and Net Income trends
Price-to-earnings and price-to-sales ratios
Free cash flow generation
Operating and net margin percentages
